Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Pharmaron Beijing Co., Ltd. Class H ( (HK:3759) ) has shared an update.
Pharmaron Beijing Co., Ltd. has announced several strategic initiatives, including the adoption of a new 2025 H Share Award Scheme to enhance employee loyalty and the expansion of its existing H Share Award Scheme to attract and retain talent. Additionally, the company plans to increase its registered capital and amend its articles of association to reflect these changes, aligning with recent regulatory updates and enhancing its operational framework.
More about Pharmaron Beijing Co., Ltd. Class H
Pharmaron Beijing Co., Ltd. is a joint stock company based in China, operating in the pharmaceutical industry. It focuses on providing comprehensive drug research and development services, including laboratory services, clinical development, and manufacturing services.
YTD Price Performance: 10.53%
Average Trading Volume: 839
Technical Sentiment Signal: Sell
Current Market Cap: €5.75B
For detailed information about 3759 stock, go to TipRanks’ Stock Analysis page.